Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: Step 1

Journal of Lipid Research

Volumn 41, Issue 9, 2000, Pages 1481-1494

  Navab, Mohamad ^a   Hama, Susan Y ^a   Cooke, C Justin ^b   Anantharamaiah, G M ^c   Chaddha, Manjula ^c   Jin, Linda ^a   Subbanagounder, Ganesamoorthy ^a   Faull, Kym F ^a   Reddy, Srinivasa T ^a   Miller, Norman E ^b   Fogelman, Alan M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c University of Alabama at Birmingham   (United States)

Author keywords

Antioxidant; Atherosclerosis; Cholesteryl linoleate hydroperoxide; HDL; HPETE; HPODE; LDL; Mildly oxidized LDL; MM LDL; Oxidized phospholipids; Paraoxonase

Indexed keywords

APOLIPOPROTEIN A1; ARYLDIALKYLPHOSPHATASE; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN;

ARTERY WALL; ARTICLE; ATHEROSCLEROSIS; ENZYME ACTIVITY; GENETIC SUSCEPTIBILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; LIPID OXIDATION; LIPOPROTEIN METABOLISM; LIVER PARENCHYMA; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; RECEPTOR BINDING; SOLID PHASE EXTRACTION; SUBENDOTHELIUM;

ANIMALS; AORTA; APOLIPOPROTEIN A-I; CELL ADHESION; CELLS, CULTURED; CHEMOTAXIS, LEUKOCYTE; ENDOTHELIUM, VASCULAR; HUMANS; LEUKOTRIENES; LINOLEIC ACIDS; LIPID PEROXIDES; LIPOPROTEINS, LDL; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MONOCYTES; MUSCLE, SMOOTH, VASCULAR; OXIDATION-REDUCTION; SOYBEANS;

EID: 0033801380     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (73)

1. Apolipoprotein-mediated removal of cellular cholesterol and phospholipids
2. Recruitment of cell phospholipids and cholesterol by apoA-II and apoA-I: Formation of nascent apolipoprotein specific HDL that differ in size, phospholipid composition and reactivity with LCAT
3. Plasma lipid transfer proteins, high-density lipoproteins and reverse cholesterol transport
4. Mechanisms of high density lipoprotein-mediated efflux of cholesterol from cell plasma membranes
5. Exchange of oxidized cholesteryl linoleate between LDL and HDL mediated by cholesteryl ester transfer protein
6. Greater selective uptake by HepG2 cells of high density lipoprotein cholesterol ester hydroperoxides than of unoxidized cholesteryl esters
7. Oxidation of high density lipoproteins I. Formation of methionine sulfoxide in apolipoproteins AI and AII is an early event that accompanies lipid peroxidation and can be enhanced by alpha-tocopherol
8. Oxidation of high density lipoproteins. II. Evidence for direct reduction of lipid hydroperoxides by methionine residues of apolipoproteins AI and AII
9. - is a lipid hydroperoxide-enriched circulating lipoprotein
10. Mechanism(s) of cell-mediated oxidation of low density lipoprotein
11. Role of oxidized low density lipoprotein in atherogenesis
12. The oxidation hypothesis of atherosclerosis
13. Antioxidants and atherosclerosis: A current assessment
14. Lipid hydroperoxide involvement in copper-dependent and independent oxidation of low density lipoproteins
15. Preparation of lipid hydroperoxide-free low-density lipoproteins
16. Increased plasma levels of lipid hydroperoxides in patients with ischemic stroke
17. Involvement of preexisting lipid hydroperoxides in Cu(2+)-stimulated oxidation of low-density lipoprotein
18. Effect of platelet activating factor-acetylhydrolase on the formation and action of minimally oxidized low density lipoprotein
19. Secretory, phospolipase A2 and lipoprotein lipase enhance 15-lipoxygenase-induced enzymic and nonenzymic lipid peroxidation in low-density lipoproteins
20. Oxidation of free fatty acids in low density lipoprotein by 15-lipoxygenase stimulates nonenzymic, alpha-tocoperol-mediated peroxidation of cholesteryl esters
21. Tocopherol-mediated peroxidation of lipoproteins: Implications for vitamin E as a potential antiatherogenic supplement
22. Disruption of the 12/15-lipoxygenase gene diminishes atherosclerosis in apoE-deficient mice
23. At last, direct evidence that lipoxygenases play a role in atherogenesis
24. Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: Steps 2 and 3
25. Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/endothelial interactions and evidence for their presence in vivo
26. Structural identification of a novel proinflammatory epoxyisoprostane phospholipid in mildly oxidized low density lipoprotein
27. Monocyte transmigration induced by modification of low density lipoprotein in cocultures of human aortic wall cells is due to induction of monocyte chemotactic protein 1 synthesis and is abolished by high density lipoprotein
28. A new antiinflammatory compound, leumedin, inhibits modification of low density lipoprotein and the resulting monocyte transmigration into the subendothelial space of cocultures of human aortic wall cells
29. Mildly oxidized LDL induces an increased apolipoprotein J/paraoxonase ratio
30. Turnover of synthetic class A amphipathic peptide analogues of exchangeable apolipoproteins in rats. Correlation with physical properties
31. Synthetic peptide analogues of apolipoproteins
32. Antiatherosclerotic properties of a model amphipathic helical peptide. Studies in transgenic mice
33. Acute effects of intravenous infusion of apoAI/phosphatidylcholine discs on plasma lipoproteins in humans
34. Effects of intravenous infusion of lipid-free apoA-I in humans
35. Production and characterization of a reconstituted high density lipoprotein for therapeutic applications
36. Reconsideration of the catalytic center and mechanism of mammalian paraoxonase/arylesterase
37. The distribution and chemical composition of ultracentrifugally separated lipoproteins of human serum
38. Modification of the Recalde method for the isolation of human monocytes
39. Protective effect of HDL associated paraoxonase-inhibition of the biological activity of minimally oxidized low density lipoprotein
40. Human plasma LDL cryopreserved with sucrose maintains in vivo kinetics indistinguishable from freshly isolated human LDL in cynomolgus monkeys
41. Rapid separation of lipid classes in high yield and purity using bonded phase columns
42. Detection of lipid hydroperoxides and hydrogen peroxide at picomole levels by an HPLC and isoluminol chemiluminescence assay
43. Oxidation of rat liver phospholipids: Comparison of pathways in homogenous solution, in liposomal suspension and in whole tissue homogenates
44. Increase in total protein following infection of CV-1 cells with SV40 virus as assayed by flow cytometry
45. Protein measurement with the Folin phenol reagent
46. A spectrophotometric microtiter-based assay for the detection of hydroperoxide derivatives of linoleic acid
47. Purification of human serum paraoxonase/arylesterase. Evidence for one esterase catalyzing both activities
48. Genetic-dietary regulation of serum paraoxonase expression and its role in atherogenesis in a mouse model
49. Induction of heme oxygenase-1 inhibits the monocyte transmigration induced by mildly oxidized LDL
50. Overexpression of apolipoprotein AII in transgenic mice converts high density lipoproteins to proinflammatory particles
51. Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis
52. Minimally modified low density lipoprotein stimulates monocyte endothelial interactions
53. Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified low-density lipoproteins
54. Only the two end helixes of eight tandem amphipathic helical domains of human apoA-I have significant lipid affinity. Implications for HDL assembly
55. Hydroxyeicosatetraenoic acids (HETEs)
56. Polyunsaturated fatty acids increase lipid radical formation induced by oxidant stress in endothelial cells
57. Ath-1, a gene determining atherosclerosis susceptibility and high density lipoprotein levels in mice
58. Effects of atherogenic diet consumption on lipoproteins in mouse strains C57BL/6 and C3H
59. Genetic evidence for a common pathway mediating oxidative stress, inflammatory gene induction and aortic fatty streak formation in mice
60. 14,15-Epoxyeicosatrienoic acid metabolism in endothelial cells
61. A role for endothelial cell lipoxygenase in the oxidative modification of low density lipoprotein
62. Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase
63. Paraoxonase active site required for protection against LDL oxidation involves its free sulfhydryl group and is different from that required for its arylesterase/paraoxonase activities: Selective action of human paraoxonase allow enzymes Q and R
64. A variant of human paraoxonase/arylesterase (HUMPONA) gene is a risk factor for coronary artery disease
65. Paraoxonase and coronary heart disease
66. Paraoxonase-gene polymorphisms associated with coronary heart disease: Support for the oxidative damage hypothesis?
67. Apolipoprotein A-I inhibits foam cell formation in apoE-deficient mice after monocyte adherence to endothelium
68. Human apolipoprotein A-I gene expression increases high density lipoprotein and suppresses atherosclerosis in the apolipoprotein E-deficient mouse
69. Plasma high-density lipoprotein concentration and development of ischaemic heart-disease
70. Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit
71. Atherosclerosis in transgenic mice overexpressing apolipoprotein A-II
72. Influence of mouse apolipoprotein A-II on plasma lipoproteins in transgenic mice